Media Centre
|
Pneumococcal
AMC receives four offers from vaccine manufacturers
12 October 2009 Update:
New registered manufacturer is publicly announced - Panacea
Biotec Ltd becomes the second firm after the Serum Institute
of India
30 September 2009 Update:
Manufacturers register to participate in the Pneumococcal
AMC - The Serum Institute of India first to be publicly announced.
23 September 2009
The Pneumococcal
AMC: Ready to Save Lives
12 June 2009 Pneumococcal disease is one of the biggest vaccine preventable killers of children today and most of these deaths occur in the developing world where no optimal vaccine is yet available. But now, thanks to the Pneumococcal Advance Market Commitment (AMC) that's all about to change. Watch the video Update: GAVI
Partners Fulfil Promise to Fight Pneumococcal Disease Update: GAVI
Alliance welcomes World Bank decision on AMC initiative Update from
Donor Committee: Pilot Advance Market Commitment for Pneumococcal
Disease Update from
Donor Committee: Work is underway to determine the optimal
terms for a pilot AMC. |
Fact SheetsAMC Fact Sheet AMC FAQs
ResourcesLearn more about the impact of pneumococcal diseases Click here |





